Effects of ESO extracts on proliferation and drug resistance of human lung adenocarcinoma drug-resistant cell line A549/DDP
Songjun SHAO,Haiyan FANG,Lingdi DUAN,Guohang YUAN,Xiangyan ZHANG,Bing GUO
DOI: https://doi.org/10.3969/j.issn.1002-266X.2017.22.001
2017-01-01
Abstract:Objective To observe the effects of ethyl acetate extracts of Squilla oratoria (ESO) on proliferation and drug resistance of human lung adenocarcinoma drug-resistant cell line A549/DDP and to investigate its mechanism.Methods We selected the A549/DDP cell line,which were treated with different concentrations of ESO (0,200,400,800 μg/ml) for 24 h.The proliferation inhibition rates of A549/DDP cells were detected by MTT assay.The cell cycle percentage was determined by flow cytometry (FCM).We used FCM to detect the Rhodamine123 (Rh123) accumulation and efflux in A549/DDP cells treated with 400 μg/mL ESO for 0,30,and 60 min.After the cells were treated with different concentrations of ESO for 24 h,the multidrug resistance 1 (MDR1) protein was detected by Western blotting.Meanwhile,we detected the ERK1/2,p-ERK1/2 protein of cells after 400 μg/mL ESO treatment for 2,4,and 8 h.Results The proliferation inhibition rates of A549/DDP cells treated with 200,400,and 800 μg/mL ESO were 19.940％ ± 0.041％,37.360％ ±0.024％,and 42.510％ ±0.008％,and significant difference was found between every two groups (all P ＜ 0.01).A549/DDP cells treated with 0,200,400,and 800 μg/mL ESO could be blocked in G2/M phase,and the proliferation inhibition rates were 24.06％ ± 2.22％,31.1％ ± 0.79％,35.64％ ± 1.15％,and 43.19％ ± 0.43％,respectively;significant difference was found between every two groups (all P ＜ 0.01).ESO increased the accumulation of Rh123 level of A549/DDP cells,reduced the efflux,and this change was more significant at 60 min than at 30 min (all P ＜ 0.01).The expression of MR1 protein was 1.22 ± 0.23,0.83 ± 0.16,0.37 ± 0.09,and 0.31 ± 0.04 in A549/DDP cells after 0,200,400,800 μg/mL of ESO treatment respectively,all P ＜0.01.However,p-ERK1/2 protein expression was up-regulated in A549/DDP cells (P ＜ 0.01),but p-ERK1/2 protein expression had no variation at different time of ESO treatment.Conclusion ESO inhibits the proliferation of A549/DDP cells through cell cycle arrest,and reverses the multidrug resistance by regulating the MAPK-ERK1/2 signaling pathway.